Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.60
Ask:
203.20
Spread: 0.60 (0.296%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jan 2017 07:00

RNS Number : 1862U
Ashmore Group PLC
16 January 2017
 

 Ashmore Group plc

+0700 16 January 2017

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2016.

Assets under management

Theme

Actual30 September 2016

(US$ billion)

Estimated31 December 2016

(US$ billion)

Movement

Q2 vs Q1

(%)

External debt

12.2

11.4

-7%

Local currency

13.7

12.4

-9%

Corporate debt

5.3

5.2

-2%

Blended debt

14.5

14.1

-3%

Equities

3.0

2.9

-3%

Alternatives

1.5

1.5

-

Multi-asset

1.2

1.1

-8%

Overlay / liquidity

3.2

3.6

+13%

Total

54.6

52.2

-4%

 

Assets under management declined by US$2.4 billion during the period, comprising negative investment performance of US$1.7 billion and net outflows of US$0.7 billion.

Overlay and blended debt delivered net inflows over the quarter, and flows were neutral in the corporate debt, equities and alternatives themes. Net outflows were mainly experienced in local currency and external debt, and were influenced by a small number of segregated account redemptions and a reduction in mutual fund flows following the US election. The multi-asset theme saw a small net outflow during the period.

The steepening of yield curves and strengthening of the US dollar led to negative investment performance in local currency, blended debt, external debt and, to a lesser extent, in corporate debt and equities, while the other investment themes were flat in performance terms over the period. Despite lower market levels, Ashmore's investment performance relative to benchmarks remained very strong throughout the quarter across all fixed income and equities investment themes.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets produced very strong investment returns in 2016 and delivered a 5% increase in Ashmore's AuM over the calendar year. This was despite the final quarter being impacted by the US election outcome, renewed strength in the US dollar, and a steepening of yield curves. While these factors interrupted the improvement in sentiment towards Emerging Markets, the effect proved to be short-lived with asset prices strengthening in December and continuing into the new year. The combination of attractive absolute and relative returns, accelerating GDP growth, and low allocations all support the expectation of further strong performance in 2017 and a return to the improving flow trend seen for most of 2016."

Notes

1. For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.2340 at 31 December 2016 (30 June 2016: 1.3234; 31 December 2015: 1.4736). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the first half of the financial year was 1.2809 (H1 2015/16: 1.5291).

Ashmore will announce its interim results in respect of the six months ended 31 December 2016 on 9 February 2017.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Kit Dunford +44 (0)20 3727 1143

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFITLLIVLID
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.